ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada · Delayed Price · Currency is CAD 0.4950
+0.0450 (10.00%)
At close: May 6, 2026
ZYUS Life Sciences Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -33.74 | -33.81 | -42.59 | -24.66 | 0.35 | -0.73 |
Depreciation & Amortization | 2.89 | 2.96 | 3.11 | 4.05 | - | - |
Stock-Based Compensation | 0.21 | 0.41 | 0.27 | 0.11 | - | - |
Other Adjustments | 0.76 | 18.87 | 26.02 | 8.31 | -0.48 | 0.68 |
Change in Receivables | 0.01 | 0.26 | -0.35 | 0.11 | 0.02 | 0.01 |
Changes in Inventories | 0.4 | 0.32 | -0.02 | 0.45 | - | - |
Changes in Accounts Payable | -0.86 | 0.7 | -5.12 | 2.34 | -0.22 | 0.02 |
Changes in Other Operating Activities | 0.4 | 0.4 | 0.74 | -0.27 | - | - |
Operating Cash Flow | -12.6 | -9.88 | -17.95 | -9.57 | -0.33 | -0.02 |
Capital Expenditures | -0.01 | -0.05 | -0.28 | -0.56 | - | - |
Sale of Property, Plant & Equipment | 0.01 | - | - | - | - | - |
Purchases of Investments | - | 1.87 | -0.06 | - | -0.97 | -0.12 |
Proceeds from Sale of Investments | - | - | - | - | 0.39 | 0.79 |
Payments for Business Acquisitions | - | - | 4.92 | -0.03 | - | - |
Other Investing Activities | - | - | - | - | 0 | 0 |
Investing Cash Flow | 1.89 | 1.83 | 4.58 | -0.59 | -0.58 | 0.67 |
Short-Term Debt Issued | 0.25 | 0.7 | 0.35 | 1.04 | - | - |
Short-Term Debt Repaid | -0.1 | -0.6 | -1.09 | -0.1 | - | - |
Net Short-Term Debt Issued (Repaid) | 0.15 | 0.1 | -0.74 | 0.94 | - | - |
Long-Term Debt Issued | 6.75 | 5 | 2.45 | 2.05 | - | - |
Long-Term Debt Repaid | -0.24 | -2 | -2.55 | - | - | - |
Net Long-Term Debt Issued (Repaid) | 6.51 | 3 | -0.1 | 2.05 | - | - |
Issuance of Common Stock | 1.64 | 3.31 | 18.44 | 6.88 | - | - |
Net Common Stock Issued (Repurchased) | 1.64 | 3.31 | 18.44 | 6.88 | - | - |
Other Financing Activities | -0.15 | -0.44 | -0.46 | -0.24 | - | - |
Financing Cash Flow | 10.73 | 5.97 | 17.14 | 9.63 | - | - |
Net Cash Flow | 0.02 | -2.08 | 3.77 | -0.54 | -0.91 | 0.65 |
Free Cash Flow | -12.61 | -9.92 | -18.23 | -10.13 | -0.33 | -0.02 |
FCF Margin | -2712.47% | -2062.79% | -5193.45% | -3400.67% | - | -8779.35% |
Free Cash Flow Per Share | -0.17 | -0.14 | -0.32 | -0.26 | -0.07 | -0.00 |
Levered Free Cash Flow | -24.27 | -26.36 | -45.01 | -15.67 | 0.13 | -0.71 |
Unlevered Free Cash Flow | -29.18 | -28.61 | -38.63 | -12.75 | -0.22 | 0.02 |